Dr Adham: J&J vaccine more attractive due to single dose


MALAYSIA finds the Johnson & Johnson (J&J) Covid-19 vaccine more attractive as recipients need to take only one dose, said Health Minister Datuk Seri Dr Adham Baba (picture).

“The Johnson & Johnson vaccine uses a one-dose method, and thus makes it very attractive to use,” he told reporters after receiving a donation of 2.7 million low dead-volume syringes worth RM891,000 from Etiqa Family Takaful Bhd at his ministry yesterday.

On Wednesday, Minister of Science, Technology and Innovation Khairy Jamaluddin Abu Bakar had announced that the government will sign a Covid-19 vaccine procurement contract with Johnson & Johnson from the US soon.

He said so far, the clinical information on this vaccine has been positive, and based on the recommendation of the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV), the Cabinet had decided to purchase the vaccine.

Dr Adham and Khairy are the co-chairmen of the JKJAV.

Commenting further on this vaccine, Dr Adham said the government had not yet determined the number of doses to be obtained from Johnson & Johnson.

Meanwhile, Dr Adham said all the syringes received yesterday would be used in the first phase of the National Covid-19 Immunisation Programme, which will start on Feb 26 involving about 500,000 frontline workers.

“This contribution can at least help the Malaysian government’s efforts in tackling the Covid-19 pandemic in the country, as well as being a good example to corporate companies that can participate in helping the government,” he said.

Prime Minister Tan Sri Muhyiddin Yassin on Tuesday announced that Malaysia would receive its first batch of the Pfizer-BioNTech Covid-19 vaccine this Sunday, while the rollout of the National Covid-19 Immunisation Programme would begin in phases from Feb 26.

The first phase of the programme, which is until April, will involve the frontliners, followed by the second phase, which is from April until August, for the high-risk groups.

The third phase involves adults aged 18 and above and will be from May till February 2022.